{"transactions":[{"id":749546,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T21:06:35.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001382909-26-000001","document":"wk-form4_1780607192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000138290926000001/wk-form4_1780607192.xml","form_type":"4"}},{"id":749545,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T21:06:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001382909-26-000001","document":"wk-form4_1780607192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000138290926000001/wk-form4_1780607192.xml","form_type":"4"}},{"id":749544,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T21:06:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111902,"source":{"system":"sec-edgar","filing":"0001382909-26-000001","document":"wk-form4_1780607192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000138290926000001/wk-form4_1780607192.xml","form_type":"4"}},{"id":750131,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41460,"kind":"person","name":"SUTTER MARTIN P","position":1,"cik":"0001017832","reported_name":"SUTTER MARTIN P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:48:01.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001017832-26-000002","document":"wk-form4_1780606079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1017832/000101783226000002/wk-form4_1780606079.xml","form_type":"4"}},{"id":750130,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41460,"kind":"person","name":"SUTTER MARTIN P","position":1,"cik":"0001017832","reported_name":"SUTTER MARTIN P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:48:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001017832-26-000002","document":"wk-form4_1780606079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1017832/000101783226000002/wk-form4_1780606079.xml","form_type":"4"}},{"id":750129,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41460,"kind":"person","name":"SUTTER MARTIN P","position":1,"cik":"0001017832","reported_name":"SUTTER MARTIN P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:48:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117523,"source":{"system":"sec-edgar","filing":"0001017832-26-000002","document":"wk-form4_1780606079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017832/000101783226000002/wk-form4_1780606079.xml","form_type":"4"}},{"id":749543,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41336,"kind":"person","name":"STALNECKER SUSAN M","position":1,"cik":"0001221375","reported_name":"STALNECKER SUSAN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:48.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001221375-26-000002","document":"wk-form4_1780606066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122137526000002/wk-form4_1780606066.xml","form_type":"4"}},{"id":749542,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41336,"kind":"person","name":"STALNECKER SUSAN M","position":1,"cik":"0001221375","reported_name":"STALNECKER SUSAN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:48.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001221375-26-000002","document":"wk-form4_1780606066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122137526000002/wk-form4_1780606066.xml","form_type":"4"}},{"id":749541,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41336,"kind":"person","name":"STALNECKER SUSAN M","position":1,"cik":"0001221375","reported_name":"STALNECKER SUSAN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:47:48.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":138239,"source":{"system":"sec-edgar","filing":"0001221375-26-000002","document":"wk-form4_1780606066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122137526000002/wk-form4_1780606066.xml","form_type":"4"}},{"id":749540,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39204,"kind":"person","name":"NOHRA GUY P","position":1,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:35.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001198330-26-000002","document":"wk-form4_1780606051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000119833026000002/wk-form4_1780606051.xml","form_type":"4"}},{"id":749539,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39204,"kind":"person","name":"NOHRA GUY P","position":1,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001198330-26-000002","document":"wk-form4_1780606051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000119833026000002/wk-form4_1780606051.xml","form_type":"4"}},{"id":749538,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39204,"kind":"person","name":"NOHRA GUY P","position":1,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:47:35.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":148892,"source":{"system":"sec-edgar","filing":"0001198330-26-000002","document":"wk-form4_1780606051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000119833026000002/wk-form4_1780606051.xml","form_type":"4"}},{"id":749537,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":749536,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":749535,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38105,"kind":"person","name":"NEELS GUIDO J","position":1,"cik":"0001222362","reported_name":"NEELS GUIDO J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:47:18.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117523,"source":{"system":"sec-edgar","filing":"0001222362-26-000008","document":"wk-form4_1780606035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000122236226000008/wk-form4_1780606035.xml","form_type":"4"}},{"id":749534,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41335,"kind":"person","name":"McMurry-Heath Michelle","position":1,"cik":"0001904156","reported_name":"McMurry-Heath Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:04.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001904156-26-000004","document":"wk-form4_1780606021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000190415626000004/wk-form4_1780606021.xml","form_type":"4"}},{"id":749533,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41335,"kind":"person","name":"McMurry-Heath Michelle","position":1,"cik":"0001904156","reported_name":"McMurry-Heath Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:47:04.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The  RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The  RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001904156-26-000004","document":"wk-form4_1780606021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000190415626000004/wk-form4_1780606021.xml","form_type":"4"}},{"id":749532,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41335,"kind":"person","name":"McMurry-Heath Michelle","position":1,"cik":"0001904156","reported_name":"McMurry-Heath Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:47:04.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77279,"source":{"system":"sec-edgar","filing":"0001904156-26-000004","document":"wk-form4_1780606021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000190415626000004/wk-form4_1780606021.xml","form_type":"4"}},{"id":749531,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39998,"kind":"person","name":"Ladone Mary Kay","position":1,"cik":"0001760737","reported_name":"Ladone Mary Kay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:46:43.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001760737-26-000004","document":"wk-form4_1780606000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000176073726000004/wk-form4_1780606000.xml","form_type":"4"}},{"id":749530,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39998,"kind":"person","name":"Ladone Mary Kay","position":1,"cik":"0001760737","reported_name":"Ladone Mary Kay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:46:43.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001760737-26-000004","document":"wk-form4_1780606000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000176073726000004/wk-form4_1780606000.xml","form_type":"4"}},{"id":749529,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39998,"kind":"person","name":"Ladone Mary Kay","position":1,"cik":"0001760737","reported_name":"Ladone Mary Kay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:46:43.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111263,"source":{"system":"sec-edgar","filing":"0001760737-26-000004","document":"wk-form4_1780606000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000176073726000004/wk-form4_1780606000.xml","form_type":"4"}},{"id":749528,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41334,"kind":"person","name":"Cowdy Philip G.","position":1,"cik":"0001679773","reported_name":"Cowdy Philip G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:46:02.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001679773-26-000006","document":"wk-form4_1780605960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000167977326000006/wk-form4_1780605960.xml","form_type":"4"}},{"id":749527,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41334,"kind":"person","name":"Cowdy Philip G.","position":1,"cik":"0001679773","reported_name":"Cowdy Philip G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:46:02.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001679773-26-000006","document":"wk-form4_1780605960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000167977326000006/wk-form4_1780605960.xml","form_type":"4"}},{"id":749526,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41334,"kind":"person","name":"Cowdy Philip G.","position":1,"cik":"0001679773","reported_name":"Cowdy Philip G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:46:02.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43982,"source":{"system":"sec-edgar","filing":"0001679773-26-000006","document":"wk-form4_1780605960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000167977326000006/wk-form4_1780605960.xml","form_type":"4"}},{"id":749525,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41333,"kind":"person","name":"Beyer Pat","position":1,"cik":"0001627985","reported_name":"Beyer Pat","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:45:46.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":25146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":25146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25146},"source":{"system":"sec-edgar","filing":"0001627985-26-000002","document":"wk-form4_1780605943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000162798526000002/wk-form4_1780605943.xml","form_type":"4"}},{"id":749524,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41333,"kind":"person","name":"Beyer Pat","position":1,"cik":"0001627985","reported_name":"Beyer Pat","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:45:46.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001627985-26-000002","document":"wk-form4_1780605943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000162798526000002/wk-form4_1780605943.xml","form_type":"4"}},{"id":749523,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41333,"kind":"person","name":"Beyer Pat","position":1,"cik":"0001627985","reported_name":"Beyer Pat","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:45:46.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108718,"source":{"system":"sec-edgar","filing":"0001627985-26-000002","document":"wk-form4_1780605943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000162798526000002/wk-form4_1780605943.xml","form_type":"4"}},{"id":749987,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38935,"kind":"person","name":"HAWKINS WILLIAM A","position":1,"cik":"0001106508","reported_name":"HAWKINS WILLIAM A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T16:46:27.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":30994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":30994,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30994},"source":{"system":"sec-edgar","filing":"0001106508-26-000003","document":"wk-form4_1780605985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1106508/000110650826000003/wk-form4_1780605985.xml","form_type":"4"}},{"id":749986,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38935,"kind":"person","name":"HAWKINS WILLIAM A","position":1,"cik":"0001106508","reported_name":"HAWKINS WILLIAM A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T16:46:27.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":39789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on June 2, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on June 2, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39789},"source":{"system":"sec-edgar","filing":"0001106508-26-000003","document":"wk-form4_1780605985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1106508/000110650826000003/wk-form4_1780605985.xml","form_type":"4"}},{"id":749985,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":38935,"kind":"person","name":"HAWKINS WILLIAM A","position":1,"cik":"0001106508","reported_name":"HAWKINS WILLIAM A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-04T16:46:27.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":39789,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":297640,"source":{"system":"sec-edgar","filing":"0001106508-26-000003","document":"wk-form4_1780605985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1106508/000110650826000003/wk-form4_1780605985.xml","form_type":"4"}},{"id":808796,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41334,"kind":"person","name":"Cowdy Philip G.","position":1,"cik":"0001679773","reported_name":"Cowdy Philip G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:19:48.000Z","date":"2021-04-01","kind":"grant","planned":false,"acquired":true,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 5, 2021, the Issuer inadvertently filed a Form 4 reporting a grant of restricted stock units that were not accepted by the Reporting Person.  As of April 1, 2021, the Reporting Person held no non-derivative or derivative securities of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"None."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"None."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"None."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0001679773-26-000004","document":"wk-form4a_1776205186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000167977326000004/wk-form4a_1776205186.xml","form_type":"4/A","original_submission_date":"2021-04-05"}},{"id":808795,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41334,"kind":"person","name":"Cowdy Philip G.","position":1,"cik":"0001679773","reported_name":"Cowdy Philip G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:19:27.000Z","date":"2021-02-11","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On February 16, 2021, the Issuer inadvertently filed a Form 4 reporting a grant of restricted stock units that were not accepted by the Reporting Person.  As of February 11, 2021, the Reporting Person held no non-derivative or derivative securities of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"None."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"None."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"None."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001679773-26-000003","document":"wk-form4a_1776205165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000167977326000003/wk-form4a_1776205165.xml","form_type":"4/A","original_submission_date":"2021-02-16"}},{"id":808794,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":13000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":808793,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5648,"price":9.06,"value":51170.88,"ownership":{"direct":true},"balance_after":177333,"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":808792,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:58.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":182981,"source":{"system":"sec-edgar","filing":"0001914936-26-000009","document":"wk-form4_1776205136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000009/wk-form4_1776205136.xml","form_type":"4"}},{"id":808791,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:18:30.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":4300,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4300},"source":{"system":"sec-edgar","filing":"0001204391-26-000006","document":"wk-form4_1776205107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000006/wk-form4_1776205107.xml","form_type":"4"}},{"id":808790,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:30.000Z","date":"2026-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1868,"price":9.06,"value":16924.08,"ownership":{"direct":true},"balance_after":64164,"source":{"system":"sec-edgar","filing":"0001204391-26-000006","document":"wk-form4_1776205107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000006/wk-form4_1776205107.xml","form_type":"4"}},{"id":808789,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:18:30.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66032,"source":{"system":"sec-edgar","filing":"0001204391-26-000006","document":"wk-form4_1776205107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000006/wk-form4_1776205107.xml","form_type":"4"}},{"id":808788,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-04-14T22:17:54.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":false,"shares":9925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":9925,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9925},"source":{"system":"sec-edgar","filing":"0001835184-26-000007","document":"wk-form4_1776205072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000007/wk-form4_1776205072.xml","form_type":"4"}},{"id":808787,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:17:54.000Z","date":"2026-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4312,"price":9.06,"value":39066.72,"ownership":{"direct":true},"balance_after":153655,"source":{"system":"sec-edgar","filing":"0001835184-26-000007","document":"wk-form4_1776205072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000007/wk-form4_1776205072.xml","form_type":"4"}},{"id":808786,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-04-14T22:17:54.000Z","date":"2026-04-10","kind":"exercise","planned":false,"acquired":true,"shares":9925,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":157967,"source":{"system":"sec-edgar","filing":"0001835184-26-000007","document":"wk-form4_1776205072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000007/wk-form4_1776205072.xml","form_type":"4"}},{"id":829280,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 74,500 RSUs vested in four approximately equal annual installments that began on March 21, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 74,500 RSUs vested in four approximately equal annual installments that began on March 21, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18625},"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":829279,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8091,"price":8.64,"value":69906.24,"ownership":{"direct":true},"balance_after":169981,"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":829278,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-24T20:59:22.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":18625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178072,"source":{"system":"sec-edgar","filing":"0001914936-26-000007","document":"wk-form4_1774385959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000007/wk-form4_1774385959.xml","form_type":"4"}},{"id":837933,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":40500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837932,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":116000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":116000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":116000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837931,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":104000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837930,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:03:39.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":61000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837929,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:03:39.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":54000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837928,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5865,"price":8.62,"value":50556.3,"ownership":{"direct":true},"balance_after":159447,"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837927,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:03:39.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":165312,"source":{"system":"sec-edgar","filing":"0001914936-26-000004","document":"wk-form4_1773781416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000004/wk-form4_1773781416.xml","form_type":"4"}},{"id":837916,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":10500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837915,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3455},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837914,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":27000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837913,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":24000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837912,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:02:32.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":16000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837911,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:02:32.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":14000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837910,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1521,"price":8.62,"value":13111.02,"ownership":{"direct":true},"balance_after":61732,"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837909,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63253,"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837908,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1501,"price":8.62,"value":12938.62,"ownership":{"direct":true},"balance_after":59753,"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837907,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:02:32.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":3455,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61254,"source":{"system":"sec-edgar","filing":"0001204391-26-000004","document":"wk-form4_1773781348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000004/wk-form4_1773781348.xml","form_type":"4"}},{"id":837926,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":26250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837925,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":8886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 35,545 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 35,545 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8886},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837924,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":92000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837923,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":83000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837922,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:01:29.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837921,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:01:29.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":35000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837920,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3802,"price":8.62,"value":32773.24,"ownership":{"direct":true},"balance_after":148042,"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837919,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":151844,"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837918,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3861,"price":8.62,"value":33281.82,"ownership":{"direct":true},"balance_after":143094,"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":837917,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-03-17T21:01:29.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":8886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146955,"source":{"system":"sec-edgar","filing":"0001835184-26-000005","document":"wk-form4_1773781286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000005/wk-form4_1773781286.xml","form_type":"4"}},{"id":838487,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":100500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838486,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":309000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":309000,"derivative":{"exercise_price":8.62,"expiration_date":"2036-03-13","underlying":"Class A Common Stock","underlying_shares":309000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838485,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":278000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":278000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":278000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838484,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T17:00:22.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":153000,"derivative":{"exercise_price":9.61,"expiration_date":"2035-03-14","underlying":"Class A Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838483,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T17:00:22.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":134000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":134000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":134000},"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838482,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":14553,"price":8.62,"value":125446.86,"ownership":{"direct":true},"balance_after":135944,"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":838481,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-17T17:00:22.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":150497,"source":{"system":"sec-edgar","filing":"0002005474-26-000004","document":"wk-form4_1773781219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000004/wk-form4_1773781219.xml","form_type":"4"}},{"id":843889,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41335,"kind":"person","name":"McMurry-Heath Michelle","position":1,"cik":"0001904156","reported_name":"McMurry-Heath Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-13T21:26:41.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":8.7866,"value":105439.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.73 to $8.81, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":44997,"source":{"system":"sec-edgar","filing":"0001904156-26-000002","document":"wk-form4_1773437199.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000190415626000002/wk-form4_1773437199.xml","form_type":"4"}},{"id":896810,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":40304,"derivative":{"underlying":"Class A Common Stock","underlying_shares":20153},"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":896809,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9429,"price":8.27,"value":77977.83,"ownership":{"direct":true},"balance_after":151812,"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":896808,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52538,"kind":"person","name":"Singleton Mark Leonard","position":1,"cik":"0001914936","reported_name":"Singleton Mark Leonard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CFO"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:30:05.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":20153,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":161241,"source":{"system":"sec-edgar","filing":"0001914936-26-000002","document":"wk-form4_1771457403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000191493626000002/wk-form4_1771457403.xml","form_type":"4"}},{"id":896807,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T23:29:29.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":8750,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001204391-26-000002","document":"wk-form4_1771457366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000002/wk-form4_1771457366.xml","form_type":"4"}},{"id":896806,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:29:29.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2133,"price":8.27,"value":17639.91,"ownership":{"direct":true},"balance_after":57799,"source":{"system":"sec-edgar","filing":"0001204391-26-000002","document":"wk-form4_1771457366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000002/wk-form4_1771457366.xml","form_type":"4"}},{"id":896805,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52537,"kind":"person","name":"CHURCH KATRINA J","position":1,"cik":"0001204391","reported_name":"CHURCH KATRINA J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Compliance Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:29:29.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59932,"source":{"system":"sec-edgar","filing":"0001204391-26-000002","document":"wk-form4_1771457366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000120439126000002/wk-form4_1771457366.xml","form_type":"4"}},{"id":896804,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T23:28:48.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":false,"shares":12980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":25960,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12980},"source":{"system":"sec-edgar","filing":"0001835184-26-000003","document":"wk-form4_1771457326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000003/wk-form4_1771457326.xml","form_type":"4"}},{"id":896803,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:28:48.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6327,"price":8.27,"value":52324.29,"ownership":{"direct":true},"balance_after":138069,"source":{"system":"sec-edgar","filing":"0001835184-26-000003","document":"wk-form4_1771457326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000003/wk-form4_1771457326.xml","form_type":"4"}},{"id":896802,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":52536,"kind":"person","name":"D'Adamio Anthony","position":1,"cik":"0001835184","reported_name":"D'Adamio Anthony","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Class A Common Stock","published_at":"2026-02-18T23:28:48.000Z","date":"2026-02-15","kind":"exercise","planned":false,"acquired":true,"shares":12980,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144396,"source":{"system":"sec-edgar","filing":"0001835184-26-000003","document":"wk-form4_1771457326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000183518426000003/wk-form4_1771457326.xml","form_type":"4"}},{"id":940170,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":187500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":940169,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":41717,"price":8.03,"value":334987.51,"ownership":{"direct":true},"balance_after":116997,"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":940168,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":60076,"kind":"person","name":"Claypoole Robert E","position":1,"cik":"0002005474","reported_name":"Claypoole Robert E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-01-13T17:30:00.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158714,"source":{"system":"sec-edgar","filing":"0002005474-26-000002","document":"wk-form4_1768343397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2005474/000200547426000002/wk-form4_1768343397.xml","form_type":"4"}},{"id":977583,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":39204,"kind":"person","name":"NOHRA GUY P","position":1,"cik":"0001198330","reported_name":"NOHRA GUY P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-08T22:02:29.000Z","date":"2025-12-04","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":7.5658,"value":75658.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.56 to $7.60, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":116610,"source":{"system":"sec-edgar","filing":"0001198330-25-000003","document":"wk-form4_1765231346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000119833025000003/wk-form4_1765231346.xml","form_type":"4"}},{"id":1003714,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41335,"kind":"person","name":"McMurry-Heath Michelle","position":1,"cik":"0001904156","reported_name":"McMurry-Heath Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-10T22:08:51.000Z","date":"2025-11-07","kind":"sale","planned":false,"acquired":false,"shares":17701,"price":7.4151,"value":131254.6851,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.36 to $7.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":56997,"source":{"system":"sec-edgar","filing":"0001904156-25-000004","document":"wk-form4_1762812528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000190415625000004/wk-form4_1762812528.xml","form_type":"4"}},{"id":1116320,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-10T21:49:16.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":7575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested on June 6, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7575},"source":{"system":"sec-edgar","filing":"0001578563-25-000316","document":"wk-form4_1749592150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000316/wk-form4_1749592150.xml","form_type":"4"}},{"id":1116319,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-10T21:49:16.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":7575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79620,"source":{"system":"sec-edgar","filing":"0001578563-25-000316","document":"wk-form4_1749592150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000316/wk-form4_1749592150.xml","form_type":"4"}},{"id":1121282,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T13:22:27.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":32282,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001578563-25-000312","document":"wk-form4_1749129741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000312/wk-form4_1749129741.xml","form_type":"4"}},{"id":1121281,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T13:22:27.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested on June 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested on June 2, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":26493},"source":{"system":"sec-edgar","filing":"0001578563-25-000312","document":"wk-form4_1749129741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000312/wk-form4_1749129741.xml","form_type":"4"}},{"id":1121280,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":22536,"kind":"person","name":"Bartholdson John A.","position":1,"cik":"0001382909","reported_name":"Bartholdson John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-05T13:22:27.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":72045,"source":{"system":"sec-edgar","filing":"0001578563-25-000312","document":"wk-form4_1749129741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856325000312/wk-form4_1749129741.xml","form_type":"4"}},{"id":1123625,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41460,"kind":"person","name":"SUTTER MARTIN P","position":1,"cik":"0001017832","reported_name":"SUTTER MARTIN P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T01:30:50.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":32282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."}],"balance_after":32282,"derivative":{"underlying":"Class A Common Stock","underlying_shares":32282},"source":{"system":"sec-edgar","filing":"0001578563-25-000310","document":"wk-form4_1749087044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1017832/000157856325000310/wk-form4_1749087044.xml","form_type":"4"}},{"id":1123624,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":41460,"kind":"person","name":"SUTTER MARTIN P","position":1,"cik":"0001017832","reported_name":"SUTTER MARTIN P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T01:30:50.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":26493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested on June 2, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested on June 2, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":26493},"source":{"system":"sec-edgar","filing":"0001578563-25-000310","document":"wk-form4_1749087044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1017832/000157856325000310/wk-form4_1749087044.xml","form_type":"4"}}],"next_cursor":"2025-06-05T01:30:50.000000Z,1123624"}